| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Autoantigen RO ELISA Kit; CALR ELISA Kit; CALR protein ELISA Kit; CALR_HUMAN ELISA Kit; Calregulin ELISA Kit; Calreticulin ELISA Kit; cC1qR ELISA Kit; CRP55 ELISA Kit; CRT ELISA Kit; CRTC ELISA Kit; Endoplasmic reticulum resident protein 60 ELISA Kit; Epididymis secretory sperm binding protein Li 99n ELISA Kit; ERp60 ELISA Kit; FLJ26680 ELISA Kit; grp60 ELISA Kit; HACBP ELISA Kit; HEL S 99n ELISA Kit; RO ELISA Kit; Sicca syndrome antigen A (autoantigen Ro; calreticulin) ELISA Kit; Sicca syndrome antigen A ELISA Kit; SSA ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, urine,tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Calreticulin (CALR) is a biological molecule commonly studied in tags & cell markers research. Receptors mediate cellular responses to ligands and can be regulated through expression, shedding, and internalization.
UniProt: P27797
Biological context
Researchers often monitor Calreticulin in serum, plasma, urine, and tissue homogenates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Calreticulin may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Calreticulin may also appear under names such as Autoantigen RO and CALR. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Calreticulin participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
A non-invasive model for diagnosis of primary Sjogren's disease based on salivary biomarkers, serum autoantibodies, and Schirmer's test
X Zhang, Z Liao, Y Chen, H Lu, A Wang, Y Shi,Arthritis Research & Therapy,2024
Annexin A1, Calreticulin and High Mobility Group Box 1 are elevated in Secondary Progressive Multiple Sclerosis: Does Immunogenic Cell Death Occur in Multiple Sclerosis?
L Zhang,/,2024
Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes
C Zheng,Journal of Extracellular Vesicles,2021
The Role of Soluble Low-Density Lipoprotein Receptor-Related Protein-1 in Obstructive Sleep Apnoea
M Meszaro,Journal of Clinical Medicine,2021
Role of Plasma Calreticulin in the Prediction of Severity in Septic Patients
Zhiheng Xu, et al,Disease Markers,2019
Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia
Molica S. et al,Br J Haematol,2016